Selected article for: "case report and China case"

Author: Al Lawati, Redha; Al Busaidi, Nasser; Al Umairi, Rashid; Al Busaidy, Merah; Al Naabi, Hanan Hamed; Khamis, Faryal
Title: COVID-19 and Pulmonary Mycobacterium Tuberculosis Coinfection
  • Cord-id: zbv7xy3h
  • Document date: 2021_9_28
  • ID: zbv7xy3h
    Snippet: The Coronavirus disease-2019 (COVID-19) outbreak was classified as a global pandemic by the World Health Organization on 11 March 2020. It is caused by the novel severe acute respiratory syndrome coronavirus 2. The virus affects mainly the human respiratory system. Mycobacterium tuberculosis (TB) is another respiratory infection known to affect humans and may share joint clinical presentations and risk factors with COVID-19 infection. Therefore, clinicians must have a high index of suspicion tha
    Document: The Coronavirus disease-2019 (COVID-19) outbreak was classified as a global pandemic by the World Health Organization on 11 March 2020. It is caused by the novel severe acute respiratory syndrome coronavirus 2. The virus affects mainly the human respiratory system. Mycobacterium tuberculosis (TB) is another respiratory infection known to affect humans and may share joint clinical presentations and risk factors with COVID-19 infection. Therefore, clinicians must have a high index of suspicion that the two infections might coexist so that there is no delay in diagnosis and starting the appropriate treatment. There are few case reports about TB and COVID-19 coinfection. The first case report ever was from China and there have been a few others around the world. Here, we report two cases of coexisting COVID-19 and newly diagnosed pulmonary TB infection in Oman.

    Search related documents:
    Co phrase search for related documents
    • absolute lymphocyte count and lopinavir ritonavir: 1
    • absolute lymphocyte count and lung disease: 1, 2, 3, 4, 5
    • absolute lymphocyte count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absolute neutrophil and lung disease: 1, 2
    • absolute neutrophil and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absolute neutrophil count and lung disease: 1, 2
    • absolute neutrophil count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active smoker and lopinavir ritonavir: 1
    • active tb disease and lung disease: 1
    • admission day and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • admission day and lung damage: 1, 2, 3, 4
    • admission day and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • admission day and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lopinavir ritonavir and lung damage: 1, 2, 3, 4, 5, 6
    • lopinavir ritonavir and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • lopinavir ritonavir and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • lung damage and lymphocyte count: 1, 2, 3, 4, 5, 6